A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Artios Pharma Ltd
Artios Pharma Ltd
Novartis
National Cancer Institute (NCI)
Frontier Medicines Corporation
Boehringer Ingelheim
Roswell Park Cancer Institute
Bristol-Myers Squibb
Genmab
Revolution Medicines, Inc.
BioNTech SE
Massachusetts General Hospital
PMV Pharmaceuticals, Inc
M.D. Anderson Cancer Center
Novartis
M.D. Anderson Cancer Center
HonorHealth Research Institute
National Institutes of Health Clinical Center (CC)
Verastem, Inc.
M.D. Anderson Cancer Center
BioNTech SE
Akeso
National Cancer Institute (NCI)
Neonc Technologies, Inc.
Icahn School of Medicine at Mount Sinai
Institut du Cancer de Montpellier - Val d'Aurelle
Eisai Inc.
Ipsen
Second Affiliated Hospital, School of Medicine, Zhejiang University
Blue Earth Diagnostics
Sichuan Enray Pharmaceutical Sciences Company
Children's Oncology Group
A2 Biotherapeutics Inc.
AstraZeneca
Merus B.V.
Arvinas Inc.
Icahn School of Medicine at Mount Sinai
Essen Biotech
Essen Biotech